These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31862828)

  • 1. Comment on Jakubowicz et al. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial. Diabetes Care 2019;42:2171-2180.
    Saraiva IE
    Diabetes Care; 2020 Jan; 43(1):e12. PubMed ID: 31862828
    [No Abstract]   [Full Text] [Related]  

  • 2. Response to Comment on Jakubowicz et al. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial. Diabetes Care 2019;42:2171-2180.
    Froy O
    Diabetes Care; 2020 Jan; 43(1):e13-e14. PubMed ID: 31862829
    [No Abstract]   [Full Text] [Related]  

  • 3. Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial.
    Jakubowicz D; Landau Z; Tsameret S; Wainstein J; Raz I; Ahren B; Chapnik N; Barnea M; Ganz T; Menaged M; Mor N; Bar-Dayan Y; Froy O
    Diabetes Care; 2019 Dec; 42(12):2171-2180. PubMed ID: 31548244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Not Available].
    Müssig K
    MMW Fortschr Med; 2020 Jun; 162(11):28. PubMed ID: 32514966
    [No Abstract]   [Full Text] [Related]  

  • 5. Influences of Breakfast on Clock Gene Expression and Postprandial Glycemia in Healthy Individuals and Individuals With Diabetes: A Randomized Clinical Trial.
    Jakubowicz D; Wainstein J; Landau Z; Raz I; Ahren B; Chapnik N; Ganz T; Menaged M; Barnea M; Bar-Dayan Y; Froy O
    Diabetes Care; 2017 Nov; 40(11):1573-1579. PubMed ID: 28830875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062.
    Carr RD; Alexander CM
    Diabetes Care; 2014 Jul; 37(7):e161-2. PubMed ID: 24963116
    [No Abstract]   [Full Text] [Related]  

  • 7. Response to comment on Monnier et al. Magnitude of the dawn phenomenon and its impact on the overall glucose exposure in type 2 diabetes: is this of concern? Diabetes Care 2013;36:4057-4062.
    Monnier L; Colette C; Dejager S; Owens D
    Diabetes Care; 2014 Jul; 37(7):e163. PubMed ID: 24963117
    [No Abstract]   [Full Text] [Related]  

  • 8. Role of High Energy Breakfast "Big Breakfast Diet" in Clock Gene Regulation of Postprandial Hyperglycemia and Weight Loss in Type 2 Diabetes.
    Jakubowicz D; Wainstein J; Tsameret S; Landau Z
    Nutrients; 2021 May; 13(5):. PubMed ID: 34063109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circadian clocks and insulin resistance.
    Stenvers DJ; Scheer FAJL; Schrauwen P; la Fleur SE; Kalsbeek A
    Nat Rev Endocrinol; 2019 Feb; 15(2):75-89. PubMed ID: 30531917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular circadian period length inversely correlates with HbA
    Sinturel F; Makhlouf AM; Meyer P; Tran C; Pataky Z; Golay A; Rey G; Howald C; Dermitzakis ET; Pichard C; Philippe J; Brown SA; Dibner C
    Diabetologia; 2019 Aug; 62(8):1453-1462. PubMed ID: 31134308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failure.
    Marcheva B; Weidemann BJ; Taguchi A; Perelis M; Ramsey KM; Newman MV; Kobayashi Y; Omura C; Manning Fox JE; Lin H; Macdonald PE; Bass J
    Elife; 2022 Feb; 11():. PubMed ID: 35188462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
    Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
    Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence-based practice use of quick-release bromocriptine across the natural history of type 2 diabetes mellitus.
    Schwartz SS; Zangeneh F
    Postgrad Med; 2016 Nov; 128(8):828-838. PubMed ID: 27458683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meal-induced 24-hour profile of circulating glycated insulin in type 2 diabetic subjects measured by a novel radioimmunoassay.
    Lindsay JR; McKillop AM; Mooney MH; Flatt PR; Bell PM; O'harte FP
    Metabolism; 2003 May; 52(5):631-5. PubMed ID: 12759896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on Jakubowicz et al. Fasting Until Noon Triggers Increased Postprandial Hyperglycemia and Impaired Insulin Response After Lunch and Dinner in Individuals With Type 2 Diabetes: A Randomized Clinical Trial. Diabetes Care 2015;38:1820-1826.
    Ganda OP
    Diabetes Care; 2016 Feb; 39(2):e28. PubMed ID: 26798157
    [No Abstract]   [Full Text] [Related]  

  • 17. Serum from type 2 diabetes patients consuming a three-meal diet resets circadian rhythms in cultured hepatocytes.
    Tsameret S; Jakubowicz D; Landau Z; Wainstein J; Ganz T; Raz I; Chapnik N; Froy O
    Diabetes Res Clin Pract; 2021 Aug; 178():108941. PubMed ID: 34245798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dietary tartary buckwheat intake attenuates insulin resistance and improves lipid profiles in patients with type 2 diabetes: a randomized controlled trial.
    Qiu J; Liu Y; Yue Y; Qin Y; Li Z
    Nutr Res; 2016 Dec; 36(12):1392-1401. PubMed ID: 27919453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the clock gene Rev-erbα in metabolism and in the endocrine pancreas.
    Vieira E; Merino B; Quesada I
    Diabetes Obes Metab; 2015 Sep; 17 Suppl 1():106-14. PubMed ID: 26332975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. United Kingdom Prospective Diabetes Study Group.
    Ann Intern Med; 1998 Feb; 128(3):165-75. PubMed ID: 9454524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.